CD137 (4-1BB) triggering leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity

Stoll A, Bruns H, Gamali S, Saul D, Fuchs M, Nimmerjahn F, Kunz M, Peipp M, Mackensen A, Mougiakakos D (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 115-116

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

DOI: 10.1038/s41375-021-01287-1

Authors with CRIS profile

Andrej Stoll Department of Medicine 5 – Haematology and Oncology Heiko Bruns Department of Medicine 5 – Haematology and Oncology Maximilian Fuchs Lehrstuhl für Medizinische Informatik Falk Nimmerjahn Lehrstuhl für Genetik Meik Kunz Lehrstuhl für Medizinische Informatik Andreas Mackensen Lehrstuhl für Innere Medizin V Dimitrios Mougiakakos Medizinische Fakultät

Involved external institutions

Christian-Albrechts-Universität zu Kiel DE Germany (DE)

How to cite

APA:

Stoll, A., Bruns, H., Gamali, S., Saul, D., Fuchs, M., Nimmerjahn, F.,... Mougiakakos, D. (2021). CD137 (4-1BB) triggering leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity. In ONCOLOGY RESEARCH AND TREATMENT (pp. 115-116). BASEL: KARGER.

MLA:

Stoll, Andrej, et al. "CD137 (4-1BB) triggering leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2021. 115-116.

BibTeX: Download